Patents by Inventor Debkishore Mitra

Debkishore Mitra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250020550
    Abstract: Examples include a sample collection device that includes a housing, a reservoir structure and a sample capture interface. The housing includes an inlet to receive an air sample from a subject. The sample capture interface provided with the housing includes a sample capture medium. The sample capture interface is manipulatable to insert the sample capture medium into the reservoir structure. Further, the sample capture interface seals the sample capture medium within the reservoir structure. Upon insertion of the sample capture interface, the sample capture interface seals the sample capture medium within the reservoir structure.
    Type: Application
    Filed: March 22, 2024
    Publication date: January 16, 2025
    Inventors: Robert Duck, Debkishore Mitra, Spencer Sawyer, Gage Fain, Hoang Nguyen, Daniel H. Friedman
  • Publication number: 20240399372
    Abstract: Systems and methods for performing biological assays are provided herein. The systems and methods determine one or more characteristics of a nucleic acid amplification sample based on a modified optical property of the sample.
    Type: Application
    Filed: August 15, 2024
    Publication date: December 5, 2024
    Inventors: Debkishore Mitra, Frank B. Myers III, John Robert Waldeisen, Ivan Krastev Dimov
  • Publication number: 20240326052
    Abstract: The disclosure provides devices, systems and methods for the generation of encapsulated reagents and the partitioning of encapsulated reagents for use in subsequent analyses and/or processing, such as in the field of biological analyses and characterization.
    Type: Application
    Filed: June 10, 2024
    Publication date: October 3, 2024
    Inventors: Rajiv BHARADWAJ, Kevin Ness, Debkishore Mitra, Donald A. MASQUELIER, Anthony Makarewicz, Christopher Hindson, Benjamin Hindson, Serge Saxonov
  • Patent number: 12090482
    Abstract: Systems and methods for performing biological assays are provided herein. The systems and methods determine one or more characteristics of a nucleic acid amplification sample based on a modified optical property of the sample. The nucleic acid amplification sample is reacted with an optical property modifying reagent in a reaction chamber of within a sample preparation device.
    Type: Grant
    Filed: June 8, 2021
    Date of Patent: September 17, 2024
    Assignee: Pfizer Inc.
    Inventors: Debkishore Mitra, Frank B. Myers, III, John Robert Waldeisen, Ivan Krastev Dimov
  • Publication number: 20240299941
    Abstract: Selectively vented biological assay devices and methods of performing biological assays with such devices are provided herein. Disclosed devices include a selective venting clement having passively tunable porosity. The methods include controlling fluid flow within the subject devices with the selective venting element.
    Type: Application
    Filed: May 1, 2024
    Publication date: September 12, 2024
    Inventors: Debkishore Mitra, Frank B. Myers III, John Robert Waldeisen, Ivan Krastev Dimov
  • Publication number: 20240269672
    Abstract: Devices and methods for modifying optical properties of biological samples or aspects thereof are provided. The subject methods include generating a reaction product with a device and reacting the reaction product to sufficiently modify an optical property to allow detection of the modified optical property.
    Type: Application
    Filed: April 15, 2024
    Publication date: August 15, 2024
    Inventors: Frank B. Myers, III, Debkishore Mitra, John Robert Waldeisen, Ivan Krastev Dimov
  • Patent number: 12023671
    Abstract: Selectively vented biological assay devices and methods of performing biological assays with such devices are provided herein. Disclosed devices include a selective venting element having passively tunable porosity. The methods include controlling fluid flow within the subject devices with the selective venting element.
    Type: Grant
    Filed: February 22, 2022
    Date of Patent: July 2, 2024
    Assignee: Pfizer Inc.
    Inventors: Debkishore Mitra, Frank B. Myers, III, John Robert Waldeisen, Ivan Krastev Dimov
  • Patent number: 12023665
    Abstract: Devices and methods for modifying optical properties of biological samples or aspects thereof are provided. The subject methods include generating a reaction product with a device and reacting the reaction product to sufficiently modify an optical property to allow detection of the modified optical property.
    Type: Grant
    Filed: March 14, 2017
    Date of Patent: July 2, 2024
    Assignee: Pfizer Inc.
    Inventors: Frank B. Myers, III, Debkishore Mitra, John Robert Waldeisen, Ivan Krastev Dimov
  • Patent number: 12005454
    Abstract: The disclosure provides devices, systems and methods for the generation of encapsulated reagents and the partitioning of encapsulated reagents for use in subsequent analyses and/or processing, such as in the field of biological analyses and characterization.
    Type: Grant
    Filed: January 11, 2021
    Date of Patent: June 11, 2024
    Assignee: 10x Genomics, Inc.
    Inventors: Rajiv Bharadwaj, Kevin Ness, Debkishore Mitra, Donald A. Masquelier, Anthony Makarewicz, Christopher Hindson, Benjamin Hindson, Serge Saxonov
  • Publication number: 20240132944
    Abstract: Colorimetry is used to detect amplification reaction products. A sample is contacted with a reaction mix under conditions such that an amplification reaction occurs and produces an amplification reaction product if the sample contains a target nucleic acid template molecule. The reaction mix includes an enzyme for catalyzing the amplification reaction, and at least one halochromic agent. If the target nucleic acid template molecule is present, the amplification reaction changes the starting pH of the reaction mix to cause a detectable colorimetric change of the halochromic agent, thereby indicating the presence of the target nucleic acid. If the target nucleic acid template molecule is not present, the amplification reaction does not generate an adequate number of protons to sufficiently change the starting pH of the reaction mix to cause a detectable colorimetric change of the halochromic agent, thereby indicating that the amplification reaction product has not been produced.
    Type: Application
    Filed: February 20, 2023
    Publication date: April 25, 2024
    Inventors: Debkishore Mitra, Ivan Krastev Dimov, John Robert Waldeisen
  • Patent number: 11954851
    Abstract: A diagnostic system performs disease diagnostic tests using at least an optical property modifying device and a mobile device. A user provides a biological sample from a patient to the optical property modifying device that reacts with a reagent in one or more reaction chambers of the device. The user captures one or more images of the one or more reaction chambers using an optical sensor of the mobile device. The diagnostic system can determine a quality level of the images based on factors such as skew, scale, focusing, shadowing, or white-balancing. Based on an analysis of the captured image, the diagnostic system can determine a test result of a disease diagnostic test for the patient. The diagnostic system may communicate the test result, as well as instructions for the disease diagnostic test, to the user via the mobile device.
    Type: Grant
    Filed: June 30, 2021
    Date of Patent: April 9, 2024
    Assignee: Pfizer Inc.
    Inventors: Ivan Krastev Dimov, Frank B. Myers, III, John Robert Waldeisen, Debkishore Mitra
  • Publication number: 20240020836
    Abstract: A diagnostic system performs disease diagnostic tests using at least an optical property modifying device and a mobile device. A user provides a biological sample from a patient to the optical property modifying device that reacts with a reagent in one or more reaction chambers of the device. The user captures one or more images of the one or more reaction chambers using an optical sensor of the mobile device. The diagnostic system can determine a quality level of the images based on factors such as skew, scale, focusing, shadowing, or white-balancing. Based on an analysis of the captured image, the diagnostic system can determine a test result of a disease diagnostic test for the patient. The diagnostic system may communicate the test result, as well as instructions for the disease diagnostic test, to the user via the mobile device.
    Type: Application
    Filed: August 2, 2023
    Publication date: January 18, 2024
    Inventors: Ivan Krastev Dimov, Frank B. Myers, III, John Robert Waldeisen, Debkishore Mitra
  • Publication number: 20230311130
    Abstract: The present disclosure provides assay and method for using assay for streamlined assay preparation and testing. These assay are useful for pathogen (e.g., viral or bacterial) detection. The present disclosure also provides assay assemblies and means to prevent or minimize the formation of bubbles when using puncturing elements in fluidic devices or chambers.
    Type: Application
    Filed: September 4, 2021
    Publication date: October 5, 2023
    Inventors: Clay Reber, Kelly Lewis Brezoczky, Thomas Brezoczky, Frank B. Myers, III, Debkishore Mitra, Tark Abed, Alexander N. Dzigurski, Bron Davis
  • Patent number: 11584957
    Abstract: Colorimetry is used to detect amplification reaction products. A sample is contacted with a reaction mix under conditions such that an amplification reaction occurs and produces an amplification reaction product if the sample contains a target nucleic acid template molecule. The reaction mix includes an enzyme for catalyzing the amplification reaction, and at least one halochromic agent. If the target nucleic acid template molecule is present, the amplification reaction changes the starting pH of the reaction mix to cause a detectable colorimetric change of the halochromic agent, thereby indicating the presence of the target nucleic acid. If the target nucleic acid template molecule is not present, the amplification reaction does not generate an adequate number of protons to sufficiently change the starting pH of the reaction mix to cause a detectable colorimetric change of the halochromic agent, thereby indicating that the amplification reaction product has not been produced.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: February 21, 2023
    Assignee: Lucira Health, Inc.
    Inventors: Debkishore Mitra, Ivan Krastev Dimov, John Robert Waldeisen
  • Publication number: 20220280939
    Abstract: Selectively vented biological assay devices and methods of performing biological assays with such devices are provided herein. Disclosed devices include a selective venting element having passively tunable porosity. The methods include controlling fluid flow within the subject devices with the selective venting element.
    Type: Application
    Filed: February 22, 2022
    Publication date: September 8, 2022
    Inventors: Debkishore Mitra, Frank B. Myers, III, John Robert Waldeisen, Ivan Krastev Dimov
  • Publication number: 20220108439
    Abstract: A diagnostic system performs disease diagnostic tests using at least an optical property modifying device and a mobile device. A user provides a biological sample from a patient to the optical property modifying device that reacts with a reagent in one or more reaction chambers of the device. The user captures one or more images of the one or more reaction chambers using an optical sensor of the mobile device. The diagnostic system can determine a quality level of the images based on factors such as skew, scale, focusing, shadowing, or white-balancing. Based on an analysis of the captured image, the diagnostic system can determine a test result of a disease diagnostic test for the patient. The diagnostic system may communicate the test result, as well as instructions for the disease diagnostic test, to the user via the mobile device.
    Type: Application
    Filed: June 30, 2021
    Publication date: April 7, 2022
    Inventors: Ivan Krastev Dimov, Frank B. Myers, III, John Robert Waldeisen, Debkishore Mitra
  • Patent number: 11291995
    Abstract: Selectively vented biological assay devices and methods of performing biological assays with such devices are provided herein. Disclosed devices include (a) a sample receiving cartridge comprising a sample inlet and one or more reaction chambers and (b) a selective venting element having passively tunable porosity. The methods include controlling fluid flow within the subject devices with the selective venting element.
    Type: Grant
    Filed: March 14, 2017
    Date of Patent: April 5, 2022
    Assignee: Lucira Health, Inc.
    Inventors: Debkishore Mitra, Frank B. Myers, III, John Robert Waldeisen, Ivan Krastev Dimov
  • Patent number: D953561
    Type: Grant
    Filed: May 5, 2020
    Date of Patent: May 31, 2022
    Assignee: Lucira Health, Inc.
    Inventors: Clay Reber, Kelly Lewis Brezoczky, Thomas Brezoczky, Frank B. Myers, III, Debkishore Mitra
  • Patent number: D955598
    Type: Grant
    Filed: November 20, 2020
    Date of Patent: June 21, 2022
    Assignee: Lucira Health, Inc.
    Inventors: Clay David Reber, Christopher Frank Kelly, Frank Benson Myers, III, Ragheb El Khaja, John Robert Waldeisen, Debkishore Mitra
  • Patent number: D962470
    Type: Grant
    Filed: June 3, 2020
    Date of Patent: August 30, 2022
    Assignee: Lucira Health, Inc.
    Inventors: Clay Reber, Kelly Lewis Brezoczky, Thomas Brezoczky, Frank B. Myers, III, Debkishore Mitra